Mark S. Bleiweis

ORCID: 0000-0002-1818-0009
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mechanical Circulatory Support Devices
  • Congenital Heart Disease Studies
  • Cardiac Structural Anomalies and Repair
  • Transplantation: Methods and Outcomes
  • Cardiac Arrest and Resuscitation
  • Cardiac Valve Diseases and Treatments
  • Infective Endocarditis Diagnosis and Management
  • Organ Transplantation Techniques and Outcomes
  • Aortic Disease and Treatment Approaches
  • Congenital Diaphragmatic Hernia Studies
  • Coronary Artery Anomalies
  • Tracheal and airway disorders
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cardiac Ischemia and Reperfusion
  • Cardiovascular Issues in Pregnancy
  • Cardiac and Coronary Surgery Techniques
  • Cardiac Imaging and Diagnostics
  • Cardiac Arrhythmias and Treatments
  • Pulmonary Hypertension Research and Treatments
  • Renal Transplantation Outcomes and Treatments
  • Respiratory Support and Mechanisms
  • Vascular anomalies and interventions
  • Cardiac pacing and defibrillation studies
  • Advanced X-ray and CT Imaging
  • Viral Infections and Immunology Research

University of Florida
2016-2025

Florida College
2009-2024

University of Florida Health
2016-2024

Adult Congenital Heart Association
2024

University of Miami Hospital
2016-2023

UF Health Shands Hospital
2009-2023

American Academy of Dermatology
2023

Jacobs (United States)
2023

University of Florida Health Science Center
2017-2021

Faculty of 1000 (United States)
2021

Recent data suggest that the Berlin Heart EXCOR Pediatric ventricular assist device is superior to extracorporeal membrane oxygenation for bridge heart transplantation. Published are limited 1 in 4 children who received as part of US clinical trial. We analyzed outcomes all characterize an unselected cohort and identify risk factors mortality facilitate patient selection.This multicenter, prospective study involved implanted with at 47 centers from May 2007 through December 2010. Multiphase...

10.1161/circulationaha.112.000685 article EN Circulation 2013-03-29

We reviewed our experience with lung transplant for cystic fibrosis (CF) over a 10-year period to identify factors influencing long-term survival.One hundred and twenty-three patients CF have undergone 131 procedures at institution; 114 had bilateral sequential transplants (DLTX) nine lower lobe from living donors. Three retransplant acute graft failure, five late bronchiolitis obliterans syndrome (BOS). Kaplan-Meier survival was calculated the entire cohort subsets higher risk of death...

10.1016/s1010-7940(02)00376-7 article EN European Journal of Cardio-Thoracic Surgery 2002-10-01

We retrospectively compared anticoagulation with heparin and bivalirudin for 32 consecutive children under 18 years old during extracorporeal membrane oxygenation (ECMO) in our pediatric cardiac intensive care unit (PCICU). Between September 2015 January 2018, 14 patients received heparin, 13 venoarterial (VA), 1 venovenous (VV). From February 2018 to 2019, (all VA). The mean (standard deviation [SD]) percentage of time therapeutic activated partial thromboplastin clotting was 54 (14%) 57...

10.1097/mat.0000000000001291 article EN ASAIO Journal 2020-10-06

Abstract Mitochondrial trifunctional protein deficiency is a long-chain fatty acid disorder that may include manifestations of severe cardiomyopathy and arrhythmias. The pathophysiology for the presentation unclear but an indicator worse outcomes. Triheptanoin, synthetic medium chain triglyceride, has been reported to reverse in some individuals, there limited literature cases. We describe neonatal onset disease whose clinical course was not improved despite mechanical support triheptanoin.

10.1017/s1047951124026386 article EN cc-by Cardiology in the Young 2025-01-09

Venoarterial extracorporeal membrane oxygenation weaning strategies are not standardized. When dealing with patients complex physiologies and borderline haemodynamics, it is prudent to have a fail-safe method of approaching decannulation from oxygenation. Standardizing the strategy pump-controlled retrograde trial off protocol seems feasible alternative traditional venoarterial approaches. We advocate that having for could be done consistently, reliably validly assess patient's ability...

10.1510/mmcts.2024.139 article EN Multimedia Manual of Cardio-Thoracic Surgery 2025-01-14

The Berlin Heart EXCOR is a pulsatile paracorporeal ventricular assist device (VAD) for neonates, infants, children and adults with congenital or acquired severe dysfunction. VADs are routinely used as either bridge to cardiac transplantation, occasionally recovery. Our programmatic philosophy neonates infants functionally univentricular ductal-dependent systemic circulation pulmonary who at high risk staged palliation because of important factors single-ventricle VAD (sVAD) transplant. This...

10.1510/mmcts.2024.135 article EN Multimedia Manual of Cardio-Thoracic Surgery 2025-01-30

Patients with a congenital heart disease and unfavourable anatomy that are not amenable to the primary correction of defect might need ventricular assist device as bridge transplant. Pulsatile paracorporeal devices represent excellent options for supporting these patients complex conditions. The Berlin Heart EXCOR is such pulsatile device. flow more physiologic because it resembles natural circulation pumped by heart. displacement pump; therefore, risk increased haemolysis greater. If...

10.1510/mmcts.2024.125 article EN Multimedia Manual of Cardio-Thoracic Surgery 2025-02-05

Objective Limited data exist on surgical repairs for native coarctation of the aorta (Native-CoA) after year-one life. We sought to establish outcomes benchmark older Native-CoA repair patients. Methods All patients greater than one year age who underwent off-pump were identified from Society Thoracic Surgeons Congenital Heart Surgery Database (STS-CHSD) between January 1998 and December 2022. Results A total 2,898 (mean age: 6.1 years; mean weight: 23.7 kg) through left thoracotomy at 131...

10.1177/21501351241311276 article EN World Journal for Pediatric and Congenital Heart Surgery 2025-02-06

Background A gap in knowledge exists related to optimal bivalirudin dosing children. The purpose of our analysis is use quantitative methods and baseline data quickly predict the therapeutic dose for Methods We developed an internal database pediatric patients on ECMO or VAD, including patient information, doses, partial thromboplastin time (PTT) measurements throughout treatment period. fit covariance (ANCOVA) model determine best predictors dose. used five-fold cross-validation ensure was...

10.1177/02676591251324648 article EN Perfusion 2025-02-27

Kawasaki disease is a vasculitis of childhood, with the development coronary artery aneurysms well-known sequela. We present case an adolescent male who presented large left main aneurysm and describe operative repair bypass grafting.

10.1510/mmcts.2025.016 article EN Multimedia Manual of Cardio-Thoracic Surgery 2025-04-25
Coming Soon ...